Trial Profile
Liraglutide for control of perioperative blood sugar in type 2 diabetes patients within enhanced recovery after surgery (ERAS) protocols
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2014
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 29 Oct 2014 New trial record
- 19 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.